Skip to Content

Notice

Approval of Subzone Status; Romark Global Pharma, LLC Manatí, Puerto Rico

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

On September 29, 2016, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board docketed an application submitted by the Puerto Rico Industrial Development Company, grantee of FTZ 7, requesting subzone status subject to the existing activation limit of FTZ 7 on behalf of Romark Global Pharma, LLC, in Manatí, Puerto Rico.

The application was processed in accordance with the FTZ Act and Regulations, including notice in the Federal Register inviting public comment (81 FR 69039, October 5, 2016). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval.

Pursuant to the authority delegated to the FTZ Board's Executive Secretary (15 CFR 400.36(f)), the application to establish Subzone 7P is approved, subject to the FTZ Act and the Board's Start Printed Page 89433regulations, including Section 400.13, and further subject to FTZ 7's 2,000-acre activation limit.

Start Signature

Dated: December 6, 2016.

Andrew McGilvray,

Executive Secretary.

End Signature End Preamble

[FR Doc. 2016-29616 Filed 12-9-16; 8:45 am]

BILLING CODE 3510-DS-P